BridgeBio Oncology Therapeutics Inc. (BBOT) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

BridgeBio Oncology Therapeutics Inc. (BBOT) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

BBOT Income Statement

BridgeBio Oncology Therapeutics Inc. (BBOT) annual income statement — 5-year revenue, gross profit & net income history

Annual Quarterly

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23

Sales/Revenue	0	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold	0	186K	0	0	0	0	0	156K	0	0	0
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	-186K	0	0	0	0	0	-156K	0	0	0
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-	-	-	100%	-	-	-	-	-	-	-
Operating Expenses	60.19M	45.99M	43.41M	49.18M	30.09M	23.14M	21.88M	19.66M	23.87M	15.45M	41.69K
OpEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	10.96M	6.38M	5.33M	14.13M	2.65M	2.5M	2.34M	1.77M	1.36M	2.28M	0
SG&A % of Revenue	-	-	-	-	-	-	-	-	-	-	-
Research & Development	49.23M	39.8M	38.07M	35.05M	27.44M	20.64M	19.54M	17.89M	22.51M	13.17M	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	-186K	0	0	0	0	0	0	0	0	41.69K
Operating Income	-60.19M	-46.18M	-43.41M	-49.18M	-30.09M	-23.14M	-21.88M	-19.66M	-23.87M	-15.45M	-41.69K
Operating Margin %	-	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-100%	-99.59%	-98.4%	-150.11%	-26.07%	-49.76%	-52377.69%	-	-	-	-
EBITDA	-56.45M	-45.99M	-43.21M	-49M	-29.91M	-23.08M	-21.83M	-19.61M	-23.82M	-15.4M	-41.69K
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	-88.73%	-99.25%	-97.98%	-149.85%	-25.58%	-49.92%	-52252.97%	-	-	-	-
D&A (Non-Cash Add-back)	0	186K	194K	181K	181K	54K	52K	52K	52K	52K	0
EBIT	-56.45M	-46.18M	-43.41M	-49.18M	-30.09M	-23.14M	-21.88M	-19.66M	-23.87M	-15.45M	-41.69K
Net Interest Income	3.55M	3.94M	4.42M	3.44M	2.08M	1.81M	2.25M	2.56M	2.44M	1.21M	0
Interest Income	3.55M	3.94M	4.42M	3.44M	2.08M	1.81M	2.25M	2.56M	2.44M	1.21M	0
Interest Expense	0	0	0	0	0	0	0	0	0	0	0
Other Income/Expense	3.73M	4.07M	4.61M	4.42M	1.66M	1.08M	2.17M	2.34M	2.36M	1.17M	0
Pretax Income	-56.45M	-42.11M	-38.8M	-44.76M	-28.43M	-22.05M	-19.69M	-17.32M	-21.82M	-15.44M	-41.69K
Pretax Margin %	-	-	-	-	-	-	-	-	-	-	-
Income Tax	0	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Income	-56.45M	-42.11M	-38.8M	-44.76M	-28.43M	-22.05M	-19.69M	-17.32M	-21.82M	-15.44M	-41.69K
Net Margin %	-	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-98.54%	-90.91%	-97.07%	-158.37%	-30.3%	-42.82%	-47120.09%	-	-	-	-
Net Income (Continuing)	-56.45M	-42.11M	-38.8M	-44.76M	-28.43M	-22.05M	1.95M	-17.32M	2.21M	1.1M	-41.69K
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-705.20	-1.35	-1.25	-1.90	-1.21	-0.94	0.12	-0.74	0.09	0.05	-0.00
EPS Growth %	-58180.99%	-43.62%	-1141.67%	-156.76%	-1385.87%	-1980%	-	-	-	-	-
EPS (Basic)	-705.20	-1.35	-1.25	-1.90	-1.21	-0.94	0.12	-0.74	0.09	0.05	-0.00
Diluted Shares Outstanding	80.05K	31.14M	31.14M	23.51M	23.51M	23.51M	16.64M	23.51M	23.51M	22M	20.48M
Basic Shares Outstanding	80.05K	31.14M	31.14M	23.51M	23.51M	23.51M	16.64M	23.51M	23.51M	22M	20.48M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-